Review



small molecule compound library  (TargetMol)


Bioz Verified Symbol TargetMol is a verified supplier
Bioz Manufacturer Symbol TargetMol manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    TargetMol small molecule compound library
    Small Molecule Compound Library, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 16 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/small-molecule+screening/Target-Focused+Phenotypic+Screening+Library/pmc13538362-350-5-9
    Average 94 stars, based on 16 article reviews
    small molecule compound library - by Bioz Stars, 2026-11
    94/100 stars

    Images

    Related Articles

    other:

    Article Title: S100A8/A9-TMEM24 axis drives podocyte injury by impairing autophagy: A novel theranostic target for early diabetic nephropathy.
    Article Snippet: A compound library comprising approximately 2,800 molecules was utilized from the Topscience database, including FDA-approved drugs and natural product derivatives.

    Article Title: MD2-IN-1 restores microglial lysosomal function and attenuates amyloid pathology through TREM2-associated signaling in 5×FAD mice.
    Article Snippet: Triggering receptor expressed on myeloid cells 2 (TREM2) is a central regulator of microglial adaptation during Alzheimer’s disease (AD), yet the development of small-molecule modulators associated with TREM2 signaling remains limited.. Here, through a consensus pharmacophore-guided virtual screening strategy, MD2-IN-1 was identified as a candidate small molecule associated with TREM2 signaling.. Biolayer interferometry and cellular thermal shift assays supported cellular target engagement related to TREM2 (KD= 13.85 μM).

    Drug discovery:

    Article Title: Mitochondria-targeted tetraoxanes initiate lipid peroxidation to drive ferroptosis and tumor suppression.
    Article Snippet: Article Mitochondria-targeted tetraoxanes initiate lipid peroxidation to drive ferroptosis and tumor suppression

    Activity Assay:

    Article Title: A rapid sporozoite viability assay identifies leads and targetable enzymatic activities against the zoonotic Cryptosporidium parvum.
    Article Snippet: The mixtures were incubated at 25 ◦C for 3 h, and fluorescence signals were measured using a Cytation 5 Cell Imaging Multi-Mode Reader (BioTek Instruments) with excitation at 560 nm and emission at 590 nm. .. A library of 5000 bioactive compounds (Topscience, Shanghai, China) was screened for activity against C. parvum sporozoite viability using the luminescence ATP assay. ..

    ATP Assay:

    Article Title: A rapid sporozoite viability assay identifies leads and targetable enzymatic activities against the zoonotic Cryptosporidium parvum.
    Article Snippet: The mixtures were incubated at 25 ◦C for 3 h, and fluorescence signals were measured using a Cytation 5 Cell Imaging Multi-Mode Reader (BioTek Instruments) with excitation at 560 nm and emission at 590 nm. .. A library of 5000 bioactive compounds (Topscience, Shanghai, China) was screened for activity against C. parvum sporozoite viability using the luminescence ATP assay. ..

    Analysis:

    Article Title: Alnustone ameliorates atopic dermatitis by rebalancing TAp63/ΔNp63 to upregulate filaggrin and restore skin barrier function.
    Article Snippet: Atopic dermatitis (AD) is a chronic, pruritic, erythematous skin condition with skin barrier dysfunction, driven largely by filaggrin (FLG) deficiency; however, direct FLG-targeting therapeutics remain lacking.. To identify novel natural products capable of enhancing FLG expression, we screened an in-house natural product library using a dual-luciferase reporter assay in HaCaT keratinocytes, which revealed that alnustone dose-dependently activated the human FLG promoter.. RT-qPCR and Western blot analysis confirmed that alnustone upregulated FLG mRNA and protein levels in keratinocytes, independently of the aryl hydrocarbon receptor (AhR).



    Similar Products

    94
    TargetMol small molecule compound library
    Small Molecule Compound Library, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/small-molecule+screening/Target-Focused+Phenotypic+Screening+Library/pmc13538362-350-5-9
    Average 94 stars, based on 1 article reviews
    small molecule compound library - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    TargetMol selleck small molecule compound libraries
    Cobicistat was identified as a novel MEST inhibitor. (A) Eight binding pockets of MEST were identified using the SiteFinder module of MOE software. (B) Virtual docking screening of MEST inhibitor from a library. (C) A preliminary screening of 36 compounds was performed by SPR. (D) Binding affinity of the cobicistat to human MEST assessed by SPR. (E) Molecular structure of cobicistat small molecule. (F) Computational model and the interaction of cobicistat with MEST complex. (G) The interacting amino acids and hydrogen bonds between the complexes.
    Selleck Small Molecule Compound Libraries, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/small-molecule+screening/Target-Focused+Phenotypic+Screening+Library/pmc13481203-156-13-11
    Average 94 stars, based on 1 article reviews
    selleck small molecule compound libraries - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    86
    Novartis 2020 novartis small molecule screening deck
    Cobicistat was identified as a novel MEST inhibitor. (A) Eight binding pockets of MEST were identified using the SiteFinder module of MOE software. (B) Virtual docking screening of MEST inhibitor from a library. (C) A preliminary screening of 36 compounds was performed by SPR. (D) Binding affinity of the cobicistat to human MEST assessed by SPR. (E) Molecular structure of cobicistat small molecule. (F) Computational model and the interaction of cobicistat with MEST complex. (G) The interacting amino acids and hydrogen bonds between the complexes.
    2020 Novartis Small Molecule Screening Deck, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/small-molecule+screening/6231+gnf+inhibitor+molecule+porcupine/pm42150410-202-21-22
    Average 86 stars, based on 1 article reviews
    2020 novartis small molecule screening deck - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    86
    Chembridge small molecule screening library
    Cobicistat was identified as a novel MEST inhibitor. (A) Eight binding pockets of MEST were identified using the SiteFinder module of MOE software. (B) Virtual docking screening of MEST inhibitor from a library. (C) A preliminary screening of 36 compounds was performed by SPR. (D) Binding affinity of the cobicistat to human MEST assessed by SPR. (E) Molecular structure of cobicistat small molecule. (F) Computational model and the interaction of cobicistat with MEST complex. (G) The interacting amino acids and hydrogen bonds between the complexes.
    Small Molecule Screening Library, supplied by Chembridge, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/small-molecule+screening/chembridge+diverset+library/us12565673-81-3-14
    Average 86 stars, based on 1 article reviews
    small molecule screening library - by Bioz Stars, 2026-11
    86/100 stars
      Buy from Supplier

    94
    TargetMol covalent small molecule compound library
    Cobicistat was identified as a novel MEST inhibitor. (A) Eight binding pockets of MEST were identified using the SiteFinder module of MOE software. (B) Virtual docking screening of MEST inhibitor from a library. (C) A preliminary screening of 36 compounds was performed by SPR. (D) Binding affinity of the cobicistat to human MEST assessed by SPR. (E) Molecular structure of cobicistat small molecule. (F) Computational model and the interaction of cobicistat with MEST complex. (G) The interacting amino acids and hydrogen bonds between the complexes.
    Covalent Small Molecule Compound Library, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/small-molecule+screening/Target-Focused+Phenotypic+Screening+Library/pm40676218-186-7-13
    Average 94 stars, based on 1 article reviews
    covalent small molecule compound library - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    TargetMol small molecule compound libraries
    Cobicistat was identified as a novel MEST inhibitor. (A) Eight binding pockets of MEST were identified using the SiteFinder module of MOE software. (B) Virtual docking screening of MEST inhibitor from a library. (C) A preliminary screening of 36 compounds was performed by SPR. (D) Binding affinity of the cobicistat to human MEST assessed by SPR. (E) Molecular structure of cobicistat small molecule. (F) Computational model and the interaction of cobicistat with MEST complex. (G) The interacting amino acids and hydrogen bonds between the complexes.
    Small Molecule Compound Libraries, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/small-molecule+screening/Target-Focused+Phenotypic+Screening+Library/pm41067316-72-23-28
    Average 94 stars, based on 1 article reviews
    small molecule compound libraries - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc small molecule dpp4 screening model
    Cobicistat was identified as a novel MEST inhibitor. (A) Eight binding pockets of MEST were identified using the SiteFinder module of MOE software. (B) Virtual docking screening of MEST inhibitor from a library. (C) A preliminary screening of 36 compounds was performed by SPR. (D) Binding affinity of the cobicistat to human MEST assessed by SPR. (E) Molecular structure of cobicistat small molecule. (F) Computational model and the interaction of cobicistat with MEST complex. (G) The interacting amino acids and hydrogen bonds between the complexes.
    Small Molecule Dpp4 Screening Model, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/small-molecule+screening/dpp4+antibody/pm40597132-271-0-25
    Average 90 stars, based on 1 article reviews
    small molecule dpp4 screening model - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Broad Institute Inc high content screening of small molecules
    Cobicistat was identified as a novel MEST inhibitor. (A) Eight binding pockets of MEST were identified using the SiteFinder module of MOE software. (B) Virtual docking screening of MEST inhibitor from a library. (C) A preliminary screening of 36 compounds was performed by SPR. (D) Binding affinity of the cobicistat to human MEST assessed by SPR. (E) Molecular structure of cobicistat small molecule. (F) Computational model and the interaction of cobicistat with MEST complex. (G) The interacting amino acids and hydrogen bonds between the complexes.
    High Content Screening Of Small Molecules, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/small-molecule+screening/high+throughput+screening/us12325866-1081-17-23
    Average 90 stars, based on 1 article reviews
    high content screening of small molecules - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    WuXi AppTec small molecule screening and initial compound retesting
    Cobicistat was identified as a novel MEST inhibitor. (A) Eight binding pockets of MEST were identified using the SiteFinder module of MOE software. (B) Virtual docking screening of MEST inhibitor from a library. (C) A preliminary screening of 36 compounds was performed by SPR. (D) Binding affinity of the cobicistat to human MEST assessed by SPR. (E) Molecular structure of cobicistat small molecule. (F) Computational model and the interaction of cobicistat with MEST complex. (G) The interacting amino acids and hydrogen bonds between the complexes.
    Small Molecule Screening And Initial Compound Retesting, supplied by WuXi AppTec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/small-molecule+screening/small+molecule+screening+and+initial+compound+retesting/pm40366200-605-9-15
    Average 90 stars, based on 1 article reviews
    small molecule screening and initial compound retesting - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Proteostasis Therapeutics cell-based small-molecule screening
    Cobicistat was identified as a novel MEST inhibitor. (A) Eight binding pockets of MEST were identified using the SiteFinder module of MOE software. (B) Virtual docking screening of MEST inhibitor from a library. (C) A preliminary screening of 36 compounds was performed by SPR. (D) Binding affinity of the cobicistat to human MEST assessed by SPR. (E) Molecular structure of cobicistat small molecule. (F) Computational model and the interaction of cobicistat with MEST complex. (G) The interacting amino acids and hydrogen bonds between the complexes.
    Cell Based Small Molecule Screening, supplied by Proteostasis Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/small-molecule+screening/cell+based+small+molecule+screening/pm40305178-12-4-9
    Average 90 stars, based on 1 article reviews
    cell-based small-molecule screening - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results


    Cobicistat was identified as a novel MEST inhibitor. (A) Eight binding pockets of MEST were identified using the SiteFinder module of MOE software. (B) Virtual docking screening of MEST inhibitor from a library. (C) A preliminary screening of 36 compounds was performed by SPR. (D) Binding affinity of the cobicistat to human MEST assessed by SPR. (E) Molecular structure of cobicistat small molecule. (F) Computational model and the interaction of cobicistat with MEST complex. (G) The interacting amino acids and hydrogen bonds between the complexes.

    Journal: Frontiers in Oncology

    Article Title: Targeting MEST using cobicistat as a therapeutic strategy for gastric cancer through suppressing NF-κB signaling

    doi: 10.3389/fonc.2026.1901635

    Figure Lengend Snippet: Cobicistat was identified as a novel MEST inhibitor. (A) Eight binding pockets of MEST were identified using the SiteFinder module of MOE software. (B) Virtual docking screening of MEST inhibitor from a library. (C) A preliminary screening of 36 compounds was performed by SPR. (D) Binding affinity of the cobicistat to human MEST assessed by SPR. (E) Molecular structure of cobicistat small molecule. (F) Computational model and the interaction of cobicistat with MEST complex. (G) The interacting amino acids and hydrogen bonds between the complexes.

    Article Snippet: Here, we identified a candidate MEST-inhibitory compound, cobicistat, by screening the TargetMol and Selleck small-molecule compound libraries based on its catalytic site, ASN163.

    Techniques: Binding Assay, Software, Docking Assay, Screening